Role of regulatory b cells in neuroimmunologic disorders

Journal of Neuroscience Research

Volumn 94, Issue 8, 2016, Pages 693-701

  Han, Jinming ^a   Sun, Li ^a   Fan, Xueli ^a   Wang, Zhongkun ^a   Cheng, Yun ^a   Zhu, Jie ^a,b   Jin, Tao ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

IL 10; IL 35; neuroimmunologic disorders; regulatory B cells; TGF

Indexed keywords

CD19 ANTIGEN; CD1D ANTIGEN; CD5 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 35; TRANSFORMING GROWTH FACTOR BETA;

B LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOLOGY; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH17 CELL;

EID: 84975057131     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23749     Document Type: Review

References (82)

1. + regulatory B cells in active antineutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies. Clin Exp Immunol 180:178–188.
2. Bennett JL, O'Connor KC, Bar-Or A, Zamvil SS, Hemmer B, Tedder TF, von Budingen HC, Stuve O, Yeaman MR, Smith TJ, Stadelmann C. 2015. B lymphocytes in neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm 2:e104.
3. hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32:129–140.
4. Candando KM, Lykken JM, Tedder TF. 2014. B10 cell regulation of health and disease. Immunol Rev 259:259–272.
5. Carter NA, Vasconcellos R, Rosser EC, Tulone C, Munoz-Suano A, Kamanaka M, Ehrenstein MR, Flavell RA, Mauri C. 2011. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 186:5569–5579.
6. Choi J, Leung PS, Bowlus C, Gershwin ME. 2015. IL-35 and autoimmunity: a comprehensive perspective. Clin Rev Allergy Immunol 49:327–332.
7. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11:1093–1101.
8. Compston A, Coles A. 2008. Multiple sclerosis. Lancet 372:1502–1517.
9. Correale J, Equiza TR. 2014. Regulatory B cells, helminths, and multiple sclerosis. Methods Mol Biol 1190:257–269.
10. Correale J, Farez M, Razzitte G. 2008. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 64:187–199.
11. Daien CI, Gailhac S, Mura T, Audo R, Combe B, Hahne M, Morel J. 2014. Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity. Arthritis Rheum 66:2037–2046.
12. + B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids. J Neuroimmunol 270:37–44.
13. hiCD27 and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood 125:1830–1839.
14. DiLillo DJ, Matsushita T, Tedder TF. 2010. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 1183:38–57.
15. Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, Chalasani G, Sayegh MH, Najafian N, Rothstein DM. 2011. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 121:3645–3656.
16. Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A. 2007. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 178:6092–6099.
17. Duffy SS, Lees JG, Moalem-Taylor G. 2014. The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis. Mult Scler Int 2014:285245.
18. Egwuagu CE, Yu CR. 2015. Interleukin 35-producing B cells (i35-Breg): a new mediator of regulatory B-cell functions in CNS autoimmune diseases. Crit Rev Immunol 35:49–57.
19. Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR, Mauri C. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 178:7868–7878.
20. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. 2002. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3:944–950.
21. hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 5:173ra23.
22. Furuzawa-Carballeda J, Hernandez-Molina G, Lima G, Rivera-Vicencio Y, Ferez-Blando K, Llorente L. 2013. Peripheral regulatory cells immunophenotyping in primary Sjogren's syndrome: a cross-sectional study. Arthritis Res Ther 15:R68.
23. Furuzawa-Carballeda J, Sanchez-Guerrero J, Betanzos JL, Enriquez AB, Avila-Casado C, Llorente L, Hernandez-Molina G. 2014. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjogren's syndrome. Scand J Immunol 80:432–440.
24. Goode I, Xu H, Ildstad ST. 2014. Regulatory B cells: the new “it” cell. Transplant Proc 46:3–8.
25. Guptill JT, Yi JS, Sanders DB, Guidon AC, Juel VC, Massey JM, Howard JF Jr, Scuderi F, Bartoccioni E, Evoli A, Weinhold KJ. 2015. Characterization of B cells in muscle-specific kinase antibody myasthenia gravis. Neurol Neuroimmunol Neuroinflamm 2:e77.
26. He Y, Qian H, Liu Y, Duan L, Li Y, Shi G. 2014. The roles of regulatory B cells in cancer. J Immunol Res 2014:215471.
27. Hilgenberg E, Shen P, Dang VD, Ries S, Sakwa I, Fillatreau S. 2014. Interleukin-10-producing B cells and the regulation of immunity. Curr Top Microbiol Immunol 380:69–92.
28. Holan V, Zajicova A, Javorkova E, Trosan P, Chudickova M, Pavlikova M, Krulova M. 2014. Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells. Immunology 141:577–586.
29. Hua F, Ji L, Zhan Y, Li F, Zou S, Chen L, Gao S, Li Y, Chen H, Cheng Y. 2014. Aberrant frequency of IL-10-producing B cells and its association with Treg/Th17 in adult primary immune thrombocytopenia patients. Biomed Res Int 2014:571302.
30. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD, Hall RP, St Clair EW, Tedder TF. 2011. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117:530–541.
31. Kalampokis I, Yoshizaki A, Tedder TF. 2013. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 15(Suppl 1):S1.
32. Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. 2005. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579–582.
33. Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J. 2011. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission. J Neuroimmunol 239:80–86.
34. Krumbholz M, Meinl E. 2014. B cells in MS and NMO: pathogenesis and therapy. Semin Immunopathol 36:339–350.
35. Lampropoulou V, Hoehlig K, Roch T, Neves P, Calderon Gomez E, Sweenie CH, Hao Y, Freitas AA, Steinhoff U, Anderton SM, Fillatreau S. 2008. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 180:4763–4773.
36. Lampropoulou V, Calderon-Gomez E, Roch T, Neves P, Shen P, Stervbo U, Boudinot P, Anderton SM, Fillatreau S. 2010. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol Rev 233:146–161.
37. Lee KM, Stott RT, Zhao G, SooHoo J, Xiong W, Lian MM, Fitzgerald L, Shi S, Akrawi E, Lei J, Deng S, Yeh H, Markmann JF, Kim JI. 2014. TGF-beta-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol 44:1728–1736.
38. Lemoine S, Morva A, Youinou P, Jamin C. 2009. Regulatory B cells in autoimmune diseases: how do they work? Ann N Y Acad Sci 1173:260–267.
39. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. 2004. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112.
40. Lindner S, Dahlke K, Sontheimer K, Hagn M, Kaltenmeier C, Barth TF, Beyer T, Reister F, Fabricius D, Lotfi R, Lunov O, Nienhaus GU, Simmet T, Kreienberg R, Moller P, Schrezenmeier H, Jahrsdorfer B. 2013. Interleukin-21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res 73:2468–2479.
41. Lu J, Li J, Zhu TQ, Zhang L, Wang Y, Tian FF, Yang H. 2013. Modulation of B-cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis. Inflammation 36:521–528.
42. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717.
43. Matsumoto M, Baba A, Yokota T, Nishikawa H, Ohkawa Y, Kayama H, Kallies A, Nutt SL, Sakaguchi S, Takeda K, Kurosaki T, Baba Y. 2014. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41:1040–1051.
44. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118:3420–3430.
45. Matsushita T, Horikawa M, Iwata Y, Tedder TF. 2010. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 185:2240–2252.
46. Mauri C, Bosma A. 2012. Immune regulatory function of B cells. Ann Rev Immunol 30:221–241.
47. Mauri C, Nistala K. 2014. Interleukin-35 takes the “B” line. Nat Med 20:580–581.
48. Michel L, Chesneau M, Manceau P, Genty A, Garcia A, Salou M, Elong Ngono A, Pallier A, Jacq-Foucher M, Lefrere F, Wiertlewski S, Soulillou JP, Degauque N, Laplaud DA, Brouard S. 2014. Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis. Clin Immunol 155:198–208.
49. Mizoguchi A, Bhan AK. 2006. A case for regulatory B cells. J Immunol 176:705–710.
50. Nakano S, Morimoto S, Suzuki J, Mitsuo A, Nakiri Y, Katagiri A, Nozawa K, Amano H, Tokano Y, Hashimoto H, Takasaki Y. 2007. Downregulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis. Autoimmunity 40:9–15.
51. + regulatory B cell (Breg). Immune Netw 10:247–249.
52. + T cells to T-regulatory cells. Cancer Res 71:3505–3515.
53. Pierson ER, Stromnes IM, Goverman JM. 2014. B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system. J Immunol 192:929–939.
54. Probstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, Lindberg RL, Kappos L, de Seze J, Derfuss T. 2015. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. J Neuroinflamm 12:46.
55. Quan C, Yu H, Qiao J, Xiao B, Zhao G, Wu Z, Li Z, Lu C. 2013. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. Mult Scler 19:289–298.
56. Ray A, Mann MK, Basu S, Dittel BN. 2011. A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroimmunol 230:1–9.
57. Robinson AP, Harp CT, Noronha A, Miller SD. 2014. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handbook Clin Neurol 122:173–189.
58. Roosendaal SD, Barkhof F. 2015. Imaging phenotypes in multiple sclerosis. Neuroimage Clin N Am 25:83–96.
59. Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E, Ries S, Dang VD, Jaimes Y, Daridon C, Li R, Jouneau L, Boudinot P, Wilantri S, Sakwa I, Miyazaki Y, Leech MD, McPherson RC, Wirtz S, Neurath M, Hoehlig K, Meinl E, Grutzkau A, Grun JR, Horn K, Kuhl AA, Dorner T, Bar-Or A, Kaufmann SH, Anderton SM, Fillatreau S. 2014. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507:366–370.
60. Smith AJ, Gordon TP, Macardle PJ. 2004. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjogren's syndrome. Tissue Antigens 63:255–259.
61. Sun F, Ladha SS, Yang L, Liu Q, Shi SX, Su N, Bomprezzi R, Shi FD. 2014. Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis. Muscle Nerve 49:487–494.
62. Tedder TF. 2015. B10 cells: a functionally defined regulatory B cell subset. J Immunol 194:1395–1401.
63. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. 2001. Lipopolysaccharide-activated B cells downregulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 167:1081–1089.
64. Vadasz Z, Toubi E. 2014. The many faces of B regulatory cells. Isr Med Assoc J 16:631–633.
65. Vincent A, Palace J, Hilton-Jones D. 2001. Myasthenia gravis. Lancet 357:2122–2128.
66. + follicular regulatory T (TFR) cells in CHB or CHC patients. J Transl Med 12:251.
67. Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, Wingfield PT, Kim SH, Egwuagu CE. 2014. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 20:633–641.
68. + T cell colitis through interaction with regulatory T-cell subsets. Proc Natl Acad Sci U S A 102:2010–2015.
69. Wilde B, Thewissen M, Damoiseaux J, Knippenberg S, Hilhorst M, van Paassen P, Witzke O, Cohen Tervaert JW. 2013. Regulatory B cells in ANCA-associated vasculitis. Ann Rheum Dis 72:1416–1419.
70. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. 2007. The spectrum of neuromyelitis optica. Lancet Neurol 6:805–815.
71. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG. 2015. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177–189.
72. Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B-cell-deficient mice. J Exp Med 184:2271–2278.
73. Xiang XG, Xie Q. 2015. IL-35: a potential therapeutic target for controlling hepatitis B virus infection. J Dig Dis 16:1–6.
74. Xiao S, Brooks CR, Sobel RA, Kuchroo VK. 2015. Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation. J Immunol 194:1602–1608.
75. + phenotype controls T-cell-dependent inflammatory responses. Immunity 28:639–650.
76. + regulatory B cell in peripheral blood of patients with neuromyelitis optica]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31:375–378.
77. Yang M, Rui K, Wang S, Lu L. 2013. Regulatory B cells in autoimmune diseases. Cell Mol Immunol 10:122–132.
78. Yao Y, Simard AR, Shi FD, Hao J. 2013. IL-10-producing lymphocytes in inflammatory disease. Int Rev Immunol 32:324–336.
79. Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, Kountikov EI, Spolski R, Poe JC, Leonard WJ, Tedder TF. 2012. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491:264–268.
80. Zhang J, Benedek G, Bodhankar S, Lapato A, Vandenbark AA, Offner H. 2015a. IL-10 producing B cells partially restore E2-mediated protection against EAE in PD-L1 deficient mice. J Neuroimmunol 285:129–136.
81. Zhang J, Lapato A, Bodhankar S, Vandenbark AA, Offner H. 2015b. Treatment with IL-10 producing B cells in combination with E2 ameliorates EAE severity and decreases CNS inflammation in B-cell-deficient mice. Metab Brain Dis 30:1117–1127.
82. hi regulatory B cells in patients with pemphigus. Br J Dermatol 172:101–110.